14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.981 64 days ( -568.38 % )
Last Price $3.90 -0.763 %
High/ Low $3.70 - $4.11 -11.24%
Chg 7 Days -23.53 % $5.10 $3.90
Chg 30 Days 50.95 % $2.58 $3.90
Chg 12 mos 282.35 % $1.02 $3.90
Trend - 3 mos 228.76 % Width: 48.71 %
Trend - 12 mos 52.88 % Width: 425.61 %
Pred. range - 3 mos $11.95 - $17.76 206.29 % - 355.47 %
Pred. range - 12 mos $1.49 - $7.85 -61.70 % - 101.31 %
Short MA avg 3 mos Sell Apr 26, 2024 - 6 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Apr 08, 2024 - 20 days
Long MA avg 12 mos Buy Dec 07, 2023 - 102 days
Short/Long MA avg 12 mos Buy Dec 19, 2023 - 94 days
Pivot Short Sell Apr 26, 2024 - 6 days
Bollinger Buy Apr 04, 2024 - 22 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About JanOne Inc.

JanOne. JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical co... JAN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT